AAAAAA

   
Results: 1-12 |
Results: 12
LONG-TERM ORAL PAMIDRONATE TREATMENT INHIBITS OSTEOCLASTIC BONE-RESORPTION AND BONE TURNOVER WITHOUT AFFECTING OSTEOBLASTIC FUNCTION IN MULTIPLE-MYELOMA
Authors: ABILDGAARD N RUNGBY J GLERUP H BRIXEN K KASSEM M BRINCKER H HEICKENDORFF L ERIKSEN EF NIELSEN JL
Citation: N. Abildgaard et al., LONG-TERM ORAL PAMIDRONATE TREATMENT INHIBITS OSTEOCLASTIC BONE-RESORPTION AND BONE TURNOVER WITHOUT AFFECTING OSTEOBLASTIC FUNCTION IN MULTIPLE-MYELOMA, European journal of haematology, 61(2), 1998, pp. 128-134
FAILURE OF ORAL PAMIDRONATE TO REDUCE SKELETAL MORBIDITY IN MULTIPLE-MYELOMA - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
Authors: BRINCKER H WESTIN J ABILDGAARD N GIMSING P TURESSON I HEDENUS M FORD J KANDRA A
Citation: H. Brincker et al., FAILURE OF ORAL PAMIDRONATE TO REDUCE SKELETAL MORBIDITY IN MULTIPLE-MYELOMA - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL, British Journal of Haematology, 101(2), 1998, pp. 280-286
ELEVATED SERUM CONCENTRATIONS OF HEPATOCYTE GROWTH-FACTOR IN PATIENTSWITH MULTIPLE-MYELOMA
Authors: SEIDEL C BORSET M TURESSON I ABILDGAARD N SUNDAN A WAAGE A
Citation: C. Seidel et al., ELEVATED SERUM CONCENTRATIONS OF HEPATOCYTE GROWTH-FACTOR IN PATIENTSWITH MULTIPLE-MYELOMA, Blood, 91(3), 1998, pp. 806-812
ABNORMAL BONE TURNOVER IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE - ANALYSES OF TYPE-I COLLAGEN TELOPEPTIDE, OSTEOCALCIN, BONE-SPECIFIC ALKALINE-PHOSPHATASE AND PROPEPTIDES OF TYPE-I AND TYPE-III PROCOLLAGENS
Authors: VEJLGAARD T ABILDGAARD N JANS H NIELSEN JL HEICKENDORFF L
Citation: T. Vejlgaard et al., ABNORMAL BONE TURNOVER IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE - ANALYSES OF TYPE-I COLLAGEN TELOPEPTIDE, OSTEOCALCIN, BONE-SPECIFIC ALKALINE-PHOSPHATASE AND PROPEPTIDES OF TYPE-I AND TYPE-III PROCOLLAGENS, European journal of haematology, 58(2), 1997, pp. 104-108
BONE-MARROW FIBROSIS AND DISEASE-ACTIVITY IN MULTIPLE-MYELOMA MONITORED BY THE AMINOTERMINAL PROPEPTIDE OF PROCOLLAGEN-III IN SERUM
Authors: ABILDGAARD N BENDIXHANSEN K KRISTENSEN JE VEJLGAARD T RISTELI L NIELSEN JL HEICKENDORFF L
Citation: N. Abildgaard et al., BONE-MARROW FIBROSIS AND DISEASE-ACTIVITY IN MULTIPLE-MYELOMA MONITORED BY THE AMINOTERMINAL PROPEPTIDE OF PROCOLLAGEN-III IN SERUM, British Journal of Haematology, 99(3), 1997, pp. 641-648
SERUM MARKERS OF BONE METABOLISM IN MULTIPLE-MYELOMA - PROGNOSTIC VALUE OF THE CARBOXY-TERMINAL TELOPEPTIDE OF TYPE-I COLLAGEN (ICTP)
Authors: ABILDGAARD N BENTZEN SM NIELSEN JL HEICKENDORFF L
Citation: N. Abildgaard et al., SERUM MARKERS OF BONE METABOLISM IN MULTIPLE-MYELOMA - PROGNOSTIC VALUE OF THE CARBOXY-TERMINAL TELOPEPTIDE OF TYPE-I COLLAGEN (ICTP), British Journal of Haematology, 96(1), 1997, pp. 103-110
PROGNOSTIC INFORMATION OF HEPATOCYTE GROWTH-FACTOR IN SERUM OF MYELOMA PATIENTS
Authors: SEIDEL C BORSET H TURESSON I ABILDGAARD N SUNDAN A WAAGE A
Citation: C. Seidel et al., PROGNOSTIC INFORMATION OF HEPATOCYTE GROWTH-FACTOR IN SERUM OF MYELOMA PATIENTS, Blood, 90(10), 1997, pp. 1563-1563
ASSESSMENT OF BONE INVOLVEMENT IN PATIENTS WITH MULTIPLE-MYELOMA USING BONE DENSITOMETRY
Authors: ABILDGAARD N BRIXEN K KRISTENSEN JE VEJLGAARD T CHARLES P NIELSEN JL
Citation: N. Abildgaard et al., ASSESSMENT OF BONE INVOLVEMENT IN PATIENTS WITH MULTIPLE-MYELOMA USING BONE DENSITOMETRY, European journal of haematology, 57(5), 1996, pp. 370-376
INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL
Authors: HJORTH M WESTIN J DAHL IMS GIMSING P HIPPE E HOLMBERG E LAMVIK J NIELSEN JL LOFVENBERG E PALVA IP RODJER S TALSTAD I TURESSON I WISLOFF F ZADOR G AMSLERNORDIN S POLGARY M ODEN A WALLGREN A WILHELMSEN L HELLQVIST L HASSELBLOM S CARNESKOG J LINDQVIST O HOFFMAN P OLSSON K THOLEN A STOLT CM RINDNER A SVENSSON R VAART J HANSEN S ENGQVIST L LANNEMYR O NILSSON PG LINNE I LILJA G TALLROTH G HALLGREN J ANDERSSON B BILLSTROM R PERSSON S SAMUELSSON T ODEBERG H ADRIANSSON M TOVE H STOBEUS N HABBERSTAD J END T DAHLEN M ERIKSSON M ANAGRIUS N ARONSON D NEZADAL L ERIKSSON K HEDENUS M RYDE J WESTIN L ANDERSSON LO BJURMAN A FORSBERG K FORS D WIKSTROM S THULE B BOLSOY U LENNERMO K STRAND T PALVA I ALMQVIST A ISOMAA B OKSANEN K EIKA C LY B BRANDT E WEYDE K FOSSUM C LOVASEN K SPARBY JA JACOBSEN EM RINDE M NYHUS S KAHRS J STEEN T GRAVDAHL H BORGE L GROTTUM KA FLOTTEROD O STROM BR KNUTSEN H DRIVENES A PAULSEN J RIIS S HAUGE PW NESTHUS I COLL P HOLE KH SAETER T SINDRE T BERENTSEN S NES H VAGSTAD G HEIKKELA R SHAMMAS V LODEMEL B SKOGEN OR SORUM Y KVAMBE V BULL O JAEGER S INGVALDSEN PG PEDERSEN K HANSEN LT ONKIEHONG M HAUGNES T STEFANSEN D GADEBERG O ABILDGAARD N JANS H MOURITSANDERSEN T NEUBAUER B CLAUSEN NT MAGNUSSON S EYJOLFSSON G BJORNSSON S
Citation: M. Hjorth et al., INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 124(2), 1996, pp. 212
FOREARM SUBSTRATE EXCHANGE DURING HYPERINSULINEMIC HYPOGLYCEMIA IN NORMAL MAN
Authors: ABILDGAARD N ORSKOV L PETERSEN JAK ALBERTI KGMM SCHMITZ O MOLLER N
Citation: N. Abildgaard et al., FOREARM SUBSTRATE EXCHANGE DURING HYPERINSULINEMIC HYPOGLYCEMIA IN NORMAL MAN, Diabetic medicine, 12(3), 1995, pp. 218-223
CONNECTIVE-TISSUE COMPONENTS IN SERUM IN MULTIPLE-MYELOMA - ANALYSES OF PROPEPTIDE OF TYPE-I AND TYPE-III PROCOLLAGENS, TYPE-I COLLAGEN TELOPEPTIDE, AND HYALURONAN
Authors: ABILDGAARD N NIELSEN JL HEICKENDORFF L
Citation: N. Abildgaard et al., CONNECTIVE-TISSUE COMPONENTS IN SERUM IN MULTIPLE-MYELOMA - ANALYSES OF PROPEPTIDE OF TYPE-I AND TYPE-III PROCOLLAGENS, TYPE-I COLLAGEN TELOPEPTIDE, AND HYALURONAN, American journal of hematology, 46(3), 1994, pp. 173-178
PNEUMOCOCCAL SEPTICEMIA AND MENINGITIS IN VACCINATED SPLENECTOMIZED ADULT PATIENTS
Authors: ABILDGAARD N NIELSEN JL
Citation: N. Abildgaard et Jl. Nielsen, PNEUMOCOCCAL SEPTICEMIA AND MENINGITIS IN VACCINATED SPLENECTOMIZED ADULT PATIENTS, Scandinavian journal of infectious diseases, 26(5), 1994, pp. 615-617
Risultati: 1-12 |